Beta IG-H3, also known as TGFBI and RGD-CAP, is a matricellular adaptor protein that is induced in most cell types in response to TGF-beta stimulation (1‑4). The human beta IG-H3 cDNA encodes a 683 amino acid (aa) precursor that includes a 23 aa signal sequence, one EMI domain, four FAS1 domains, and one RGD motif (1). Human beta IG-H3 shares 91% and 93% aa sequence identity with mouse and porcine beta IG-H3, respectively. beta IG-H3 is expressed as a 75 kDa protein with no post‑translational additions (5). Following secretion, cleavages at multiple positions near the C-terminal end liberate peptides with pro-apoptotic activity (5,6). Peptides that encompass the RGD motif contribute to the pro-apoptotic effects of TGF-beta (6). FAS1 domains contain YH motifs that are characterized by conserved Tyr and His residues (7). The YH motifs in each of the FAS1 domains enable beta IG-H3 binding to matrix Fibronectin, Collagen I, and Collagen VI (3, 8‑10) in addition to cell expressed Integrins alpha V beta 3, alpha V beta 5, and alpha 3 beta 1 (7, 8, 11, 12). The expression of beta IG-H3 is modulated at particular developmental stages in some cell types. It is upregulated in keratinocytes and immature dendritic cells but downregulated in osteoblasts (8, 11, 13). It promotes keratinocyte differentiation but blocks osteoblast differentiation (8,11). beta IG-H3 stimulates macrophage endocytosis and vascular endothelial cell proliferation and migration (12, 13). High glucose levels induce beta IG-H3 in renal proximal tubule cells which is predictive of diabetic nephropathy (3). Several point mutations (clustered in the fourth FAS1 domain) of beta IG-H3 are linked to different corneal dystrophies (14). beta IG-H3 is downregulated in many cancers (4, 15) and functions as a suppressor of tumorigenicity when overexpressed (2, 4, 15).
Human beta IG-H3 Antibody [Biotin]
R&D Systems | Catalog # BAF2935
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Gly24-His683
Accession # Q15582
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human beta IG-H3 Antibody [Biotin]
Human beta IG-H3 ELISA Standard Curve
Recombinant Human beta IG‑H3 (Catalog # 3409-BG) was serially diluted and captured by Mouse Anti-Human beta IG‑H3 Monoclonal Antibody (Catalog # MAB2935) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human beta IG‑H3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2935) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)Applications for Human beta IG-H3 Antibody [Biotin]
Western Blot
Sample: Recombinant Human beta IG-H3 (Catalog # 3409-BG)
Human beta IG-H3 Sandwich Immunoassay
Reviewed Applications
Read 2 reviews rated 4 using BAF2935 in the following applications:
Formulation, Preparation, and Storage
Purification
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: beta IG-H3
References
- Skonier, J. et al. (1992) DNA Cell Biol. 11:511.
- Skonier, J. et al. (1994) DNA Cell Biol. 13:571.
- Lee, S-H. et al. (2003) Kidney Int. 64:1012.
- Zhao, Y.L. et al. (2002) Oncogene 21:7471.
- Andersen, R.B. et al. (2004) Biochemistry 43:16374.
- Kim, J-E. et al. (2003) Oncogene 22:2045.
- Kim, J-E. et al. (2002) J. Biol. Chem. 277:46159.
- Thapa, N. et al. (2005) Bone 36:232.
- Hanssen, E. et al. (2003) J. Biol. Chem. 278:24334.
- Billings, P.C. et al. (2002) J. Biol. Chem. 277:28003.
- Oh, J-E. et al. (2005) J. Biol. Chem. 280:21629.
- Nam, J-O. et al. (2003) J. Biol. Chem. 278:25902.
- Cao, W, et al. (2006) Blood 107:2777.
- Stewart, H.S. et al. (1999) Hum. Mutat. 14:126.
- Zhao, Y. et al. (2006) Mol. Carcinog. 45:84.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional beta IG-H3 Products
Product Documents for Human beta IG-H3 Antibody [Biotin]
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human beta IG-H3 Antibody [Biotin]
For research use only
Related Research Areas
Citations for Human beta IG-H3 Antibody [Biotin]
Customer Reviews for Human beta IG-H3 Antibody [Biotin] (2)
Have you used Human beta IG-H3 Antibody [Biotin]?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 for a review with an image
$10/€7/£6/$10CAN/¥1110 for a review without an image
Submit a review
-
Application: Western BlotSample Tested: See PMID 22769442Species: HumanVerified Customer | Posted 01/12/2015
-
Application: ImmunocytochemistrySample Tested: See PMID 22769442Species: HumanVerified Customer | Posted 01/12/2015
There are no reviews that match your criteria.
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Cellular Response to Hypoxia Protocols
- R&D Systems Quality Control Western Blot Protocol
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars